ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,101.24
      -0.29%
      US Tech 100
      21,156.80
      -0.70%
      Dow Jones
      44,424.25
      -0.32%
      Brent Oil
      77.625
      0.00%
      Bitcoin
      104,958.23
      0.22%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Kyverna Therapeutics Inc (KYTX) Quote

      Kyverna Therapeutics Inc

      Kyverna Therapeutics Inc (KYTX)

      NASDAQ
      3.60
      0.21
      (6.19%)
      Closed January 26 4:00PM
      Delayed by 15 minutes
      3.69
      0.09
      (2.50%)
      After Hours: 7:55PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.69
      Bid
      3.68
      Ask
      3.71
      Volume
      2,873,746
      3.33 Day's Range 3.9499
      3.22 52 Week Range 35.01
      Market Cap
      159.303M
      Previous Close
      3.39
      Open
      3.37
      Last Trade
      200
      @
      3.69
      (formt)
      Last Trade Time
      Financial Volume
      $ 10,493,687
      VWAP
      3.6516
      Average Volume (3m)
      328,556
      Shares Outstanding
      43,171,612
      Dividend Yield
      -
      PE Ratio
      -2.57
      Earnings Per Share (EPS)
      -1.4
      Revenue
      -
      Net Profit
      -60.37M

      About Kyverna Therapeutics Inc

      Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      kyvernatx.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Kyverna Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KYTX. The last closing price for Kyverna Therapeutics was $3.39. Over the last year, Kyverna Therapeutics shares have traded in a share price range of $ 3.22 to $ 35.01.

      Kyverna Therapeutics currently has 43,171,612 shares outstanding. The market capitalization of Kyverna Therapeutics is $146.35 million. Kyverna Therapeutics has a price to earnings ratio (PE ratio) of -2.57.

      Ask ADVFN Intelligence (AI)

      KYTX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      January 24 2025
      Edgar (US Regulatory)

      Form 3 - Initial statement of beneficial ownership of securities

      January 24 2025
      Edgar (US Regulatory)

      Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

      Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 23, 2025 NEW YORK, Jan. 23, 2025 /PRNewswire/...

      January 23 2025
      PR Newswire (US)

      Form 8-K - Current report

      January 21 2025
      Edgar (US Regulatory)

      Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

      Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer PR Newswire EMERYVILLE, Calif., Jan. 21, 2025 Dr. Gehchan brings decades of successful late-stage...

      January 21 2025
      PR Newswire (US)

      Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

      Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Jan. 20, 2025 NEW YORK, Jan. 20, 2025...

      January 20 2025
      PR Newswire (US)

      Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTX

      Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTX PR Newswire NEW YORK, Jan. 16...

      January 16 2025
      PR Newswire (US)

      Form 8-K - Current report

      January 13 2025
      Edgar (US Regulatory)

      Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference

      Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire EMERYVILLE, Calif., Jan. 13, 2025 Extending...

      January 13 2025
      PR Newswire (US)

      Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) Seeking Recovery for Investors - Contact The Gross Law Firm

      Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025 /PRNewswire/...

      January 13 2025
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.185.128205128213.513.74913.222243023.31789409CS
      4-0.31-7.7544.263.222727563.59684374CS
      12-1.14-23.6024844724.837.23.223285564.48677057CS
      26-5.71-60.74468085119.410.083.223615245.72062517CS
      52-30.56-89.226277372334.2535.013.2244535111.88326049CS
      156-30.56-89.226277372334.2535.013.2244535111.88326049CS
      260-30.56-89.226277372334.2535.013.2244535111.88326049CS

      KYTX - Frequently Asked Questions (FAQ)

      What is the current Kyverna Therapeutics share price?
      The current share price of Kyverna Therapeutics is $ 3.69
      How many Kyverna Therapeutics shares are in issue?
      Kyverna Therapeutics has 43,171,612 shares in issue
      What is the market cap of Kyverna Therapeutics?
      The market capitalisation of Kyverna Therapeutics is USD 146.35M
      What is the 1 year trading range for Kyverna Therapeutics share price?
      Kyverna Therapeutics has traded in the range of $ 3.22 to $ 35.01 during the past year
      What is the PE ratio of Kyverna Therapeutics?
      The price to earnings ratio of Kyverna Therapeutics is -2.57
      What is the reporting currency for Kyverna Therapeutics?
      Kyverna Therapeutics reports financial results in USD
      What is the latest annual profit for Kyverna Therapeutics?
      The latest annual profit of Kyverna Therapeutics is USD -60.37M
      What is the registered address of Kyverna Therapeutics?
      The registered address for Kyverna Therapeutics is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
      What is the Kyverna Therapeutics website address?
      The website address for Kyverna Therapeutics is kyvernatx.com
      Which industry sector does Kyverna Therapeutics operate in?
      Kyverna Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NVNINVNI Group Ltd
      $ 4.38
      (193.96%)
      		366.98M
      EVAXEvaxion Biotech AS
      $ 5.99
      (64.56%)
      		55.41M
      ELABPMGC Holdings Inc
      $ 3.0901
      (56.07%)
      		76.48M
      PCLAPicoCELA Inc
      $ 4.60
      (49.35%)
      		3.75M
      GOEVCanoo Inc
      $ 0.475
      (43.94%)
      		282.22M
      GODNUGolden Star Acquisition Corporation
      $ 3.11
      (-75.82%)
      		17.51k
      GODNGolden Star Acquisition Corporation
      $ 2.93
      (-65.67%)
      		902.76k
      NXTTNext Technology Holding Inc
      $ 1.37
      (-54.93%)
      		2.56M
      SGLYSingularity Future Technology Ltd
      $ 1.625
      (-38.45%)
      		917.77k
      WHLRLWheeler Real Estate Investment Trust Inc
      $ 90.11
      (-38.07%)
      		8
      ACONAclarion Inc
      $ 0.0557
      (28.94%)
      		811.91M
      NVNINVNI Group Ltd
      $ 4.38
      (193.96%)
      		366.98M
      RIMEAlgorhythm Holdings Inc
      $ 0.0357
      (4.69%)
      		284.97M
      GOEVCanoo Inc
      $ 0.475
      (43.94%)
      		282.22M
      NVDANVIDIA Corporation
      $ 142.62
      (-3.12%)
      		232.88M

      Discussion

      View Full Feed
      CashCowMoo CashCowMoo 9 minutes ago
      How would it be $2 if there is nothing going in?
      SBUM
      lovethatgreen lovethatgreen 11 minutes ago
      $ MONI
      MONI
      zakattack zakattack 12 minutes ago
      You make up wild fantasies that can't be proven then nothing happenes and you pretend like you don't say these crazy dreams you're the troll not me
      GNCP
      doinit doinit 13 minutes ago
      loaded more in teens,,wanted to load even more...ran out of funds,,,lol
      PTHRF
      Quikshft Quikshft 15 minutes ago
      I would just say that if things are not going well, not filing quarterly's lets them not talk about it. How much more time would you give them before concluding things are not right? Perhaps they should spend some of the proceeds from the preferred D shares sale for additional accountants.
      CRTG
      doinit doinit 16 minutes ago
      PTHRF,,,headed for dollar land
      PTHRF
      AlwaysRed AlwaysRed 18 minutes ago
      It is believed that this post was wrong just like all the rest of your posts. Fear porn works great doesn't it?

      Where is that 50 dollar silver?
      Where is that dollar collapse?
      where is that banking holiday?

      Why are you still listening to clowns?
      Think1st Think1st 19 minutes ago
      Were trying to make some money back.
      While Pointing out we are in deep hole.
      Because we never got off the ground.
      Big ideas ,didn't pan out, endless no stop filings only to restart co in new direction with now more debt,
      Co wants to get back in business to help investors
      INQD
      sunspotter sunspotter 24 minutes ago
      “ Exhibiting a complete lack of integrity must also be bliss.”

      Ask Leo and Mr. Bean.

      They’re the ones who stole your money after all, although to be fair it’s your own fault as you ignored all the warnings that brighter posters like loanranger and others gave you.
      IPIX
      HappyAlways HappyAlways 25 minutes ago
      When Pulte get his nomination hearing, he will be asked about the c-ship. That can be huge. Btw, are Congressman still allowed to trade stocks ?
      FNMA
      Steady_T Steady_T 42 minutes ago
      We know that some judges are politicized by recent court proceedings. We also know that judges are incentivized i.e. bribed some times.

      In both cases (pun intended) those are a very small minority. Powerful companies are held accountable in the court system all the time. There is no r
      NWBO
      Whalatane Whalatane 54 minutes ago
      We will know Sunday nite thru first hr of trading Monday how disruptive Deepseek may be to NVDA and US AI .
      Only upside I see is for software Co's .
      Try using it ...IMHO its impressive , free and supposedly 1/10th or less , of the cost to develop as US AI platforms

      Ki
      NVDA
      AlwaysOptimistic AlwaysOptimistic 58 minutes ago
      Greenland is in the North American Hemisphere, not European continent. Alaska is side by side with Canada. JMO, Trump probably is floating the idea because he likes the idea of a buffer from Russia closer to Europe and better access to the Arctic for security reasons just like Russia wants a buffer
      NB
      Steady_T Steady_T 59 minutes ago
      Both your post and Boi's post can, be and are, true at the same time.
      AVXL
      barnstormer barnstormer 59 minutes ago
      True Xmaster, the judge can't force the parties to settle. However, the judge can in his or her rulings and conferences with the attorney's can subtlety to strongly suggest it would be in their client's best interest to consider settling the matter. I was involved as one of the company's representat
      NWBO
      4u2nv2 4u2nv2 1 hour ago
      No hard feelings if they don't accept my offer. It was just an idea and a very serious offer. No strings attached or games being played. This is my last post about it. Let everyone wonder WTF happens. Hope I can help.
      IFUS
      4u2nv2 4u2nv2 1 hour ago
      That offer to connect IFUS with the right people was spur of the moment tonight. I do need the money. I guess my name would be in filings as a paid consultant if they accept the offer. It's all got to be legal and cash only. Any shareholders that call me looking for insider info would be cool becaus
      IFUS
      billdean8 billdean8 1 hour ago
      Not me Mexedia said 2023 United States and Ireland the two subsidiaries involved with rdar where responsible for over 300 million dollar in revenue for Mexedia in 2023. Why can't you give credit where credit is due . 2025 microcaps conference NASDAQ NYSE OTCQB OTCQB PINK mainly for major exchange mi
      RDAR
      Hoghead7 Hoghead7 1 hour ago
      Interesting read, says 13MW, $140M
      https://www.ameresco.com/ameresco-begins-construction-of-biogas-cogeneration-project-in-sacramento-california/

      Example of current partners and alliances, like Toyota and Exxonmobil
      https://www.ameresco.com/ameresco-wins-silver-in-large
      FCEL
      littlejohn littlejohn 1 hour ago
      Gulf of Mexico is first inflation Spike item

      created under Mr. Trump...

      Changing a name for no good reason

      is very costly...

      But it could be lowest inflation spike

      item proposed by possible new Trump

      policies
      236T568 236T568 2 hours ago
      How cool is this.

      https://x.com/visualfeastwang/status/1883113547057758418
      Genz2 Genz2 2 hours ago
      https://www.nist.gov/system/files/documents/2017/06/05/040813_wave_systems_response_part2.pdf
      HoldEm777 HoldEm777 2 hours ago
      I will pass. Thanks. Kinda looking at another one. It’s a Alessi pump also. :) it’s crazy cause all the same people are there posting. Kinda weird right? I have no idea why that would be the case do you?
      RDAR
      wadegarret wadegarret 2 hours ago
      Nelson, please make sense of this

      IART goes up 20% in 2 weeks, after announcing that the FDA gave them quality control warnings in 3 factories, plus IART would not reiterate Q4 eps guidance after the negative news, and they knew what Q4 was, as it was Jan already !.
      AAOI COHR GERN

      Your Recent History

      NASDAQ
      KYTX
      Kyverna Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads